Thermo Fisher Scientific (TMO) Other Operating Expenses (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Other Operating Expenses for 18 consecutive years, with $7.1 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Operating Expenses rose 10.31% year-over-year to $7.1 billion; the trailing twelve-month figure through Jun 2026 stood at $27.4 billion (up 7.91% YoY), and the FY2025 full-year result was $26.3 billion, up 4.53% from the prior year.
• Other Operating Expenses climbed to $7.1 billion in Q2 2026 per TMO's latest filing, from $6.6 billion in the prior quarter.
• Across five years, Other Operating Expenses topped out at $7.2 billion in Q4 2025 and bottomed at $6.1 billion in Q1 2025.
• Historically, Other Operating Expenses has averaged $6.5 billion across 5 years, with a median of $6.4 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Other Operating Expenses surged 36.25% in 2022, then slipped 6.56% in 2024.
• Over 5 years, Other Operating Expenses stood at $6.8 billion in 2022, then decreased by 5.13% to $6.5 billion in 2023, then climbed by 1.25% to $6.6 billion in 2024, then climbed by 9.61% to $7.2 billion in 2025, then decreased by 1.3% to $7.1 billion in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $7.1 billion, $6.6 billion, and $7.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.